Facebook
Twitter
LinkedIn
ForwardMR US Fusion Guided Prostate Biopsy (2017)
In recent years, the technique of multiparametric MR Imaging (mpMRI) of the prostate has offered the potential to alter the current paradigms for prostate cancer diagnosis, staging, and therapy. Though initially met with skepticism, mpMRI of the prostate is being rapidly adopted as a diagnostic technique in both the academic and community setting throughout the U.S. At present, the rationale for use of mpMRI in prostate cancer validation is well recognized, but many concepts await validation, both through further trials and clinical experience within the urologic community. Given the rapid adoption of prostate MRI in clinical practice, it is imperative for contemporary urologists to have a basic understanding of prostate MRI, the rational and clinical indication for MRI-targeted biopsy, and techniques for performing MRI-targeted biopsy in clinical practice.
Acknowledgements
The American Urological Association would like to thank the following companies for providing Skills Enhancement Workshop and exhibitor support of MR US Fusion Guided Prostate Biopsy:
- BK Ultrasound
- Eigen
- Exact Imaging
- Focal Healthcare
- Invivo Corporation
Target Audience
- Non-Urologist MD
- Resident
- Urologist
Learning Objectives
After attending this course, participants will be able to:
- Demonstrate the basic principles of multiparametric MR imaging of the prostate.
- Define the conceptual basis and methods for MRI to ultrasound computerized co-registration.
- Establish a practice-specific strategy for clinical implementation of MRI-targeted biopsy in patient management.
6:45 – 7:30 a.m. Registration & Breakfast
7:30 – 7:35 a.m. Introduction and Welcome
Samir Taneja, MD
7:35 – 7:45 a.m. ARS Pre-test
7:45 – 8:05 a.m. Pre-Biopsy MRI of the Prostate: Rationale and Goals
Soroush Rais-Bahrami, MD
8:05 – 8:25 a.m. Principles of Co-Registration
Preston C. Sprenkle, MD
8:25 – 8:45 a.m. MRI- Fusion Biopsy Key Concepts in Implementation
Srinivas Vourganti, MD
8:45 – 9:00 a.m. Q&A
9:00 – 9:10 a.m. Break
9:10 –10:10 a.m. Pre-Biopsy MRI and MRI-Fusion Biopsy: How We Use it in Practice
9:10 – 9:25 a.m. The UAB Experience
Soroush Rais-Bahrami, MD
9:25 – 9:40 a.m. The Yale Experience
Preston C. Sprenkle, MD
9:40 – 9:55 a.m. The NIH Experience
Peter A. Pinto, MD
9:55 – 10:10 a.m. The NYU Experience
Samir Taneja, MD
10:10 – 10:30 a.m. Available Commercial Systems for MRI Fusion
James S. Wysock, MD
10:30 – 10:40 a.m. Break
10:40 – 11:10 a.m. The Learning Curve of Fusion Biopsy and Tips for Smoothing It Out
10:40 – 10:55 a.m. NYU Experience
Samir Taneja, MD
10:55 – 11:10 a.m. NIH Experience
Peter A. Pinto, MD
11:10 a.m. – Noon Audience Questions and Panel Discussion I: Tips & Tricks for Use in Clinical Practice
All Faculty
Noon – 12:15 p.m. ARS Post-test
12:15 – 1:00 p.m. Lunch
1:00 –3:00 p.m. Skills Enhancement Workshops (non-CME)
3:00 – 3:15 p.m. Break
3:15 – 4:30 p.m. Audience Questions and Panel Discussion II: Use of Equipment in Clinical Practice
All Faculty
4:30 – 6:00 p.m. Networking Reception & Museum Tour
Course Director
Samir Taneja, MD
The James M. and Janet Riha Neissa Professor of Urologic Oncology
Professor of Urology and Radiology
Director, Division of Urologic Oncology
Co‐Director, Smilow Comprehensive Prostate Cancer Center
GU Program Leader, NYU Perlmutter Cancer Institute
Department of Urology, NYU Langone Medical Center
New York, NY
Email: samir.taneja@nyumc.org
Faculty
Peter A. Pinto, MD
Head, Prostate Section
Fellowship Director
Urologic Oncology Branch
National Cancer Institute
National Institutes of Health
Bethesda, MD
Email: pintop@mail.nih.gov
Soroush Rais‐Bahrami, MD
Assistant Professor of Urology and Radiology
University of Alabama at Birmingham
Birmingham, AL
Email: soroushraisbahrami@gmail.com
Preston C. Sprenkle, MD
Assistant Professor
Department of Urology
Yale University
New Haven, CT
Email: preston.sprenkle@yale.edu
Srinivas Vourganti, MD
Assistant Professor
Urologic Oncology
Rush University Medical Center
Chicago, IL
Email: srinivas_vourganti@rush.edu
James S. Wysock, MD
Assistant Professor
Division of Urologic Oncology
Chief, Bellevue Urology Service
NYU Langone Medical Center
New York, NY
Email: wysock@gmail.com
Disclosures
| Name | Faculty Role | Company | COI Role | Financial | Date Disclosed |
|---|---|---|---|---|---|
| Peter A. Pinto, MD | Faculty | Nothing to Disclose | |||
| Srinivas Vourganti, MD | Faculty | Nothing to Disclose | |||
| Soroush Rais-Bahrami ,M.D. | Faculty | Nothing to Disclose | |||
| James S. Wysock, MD | Faculty | Nothing to Disclose | |||
| Preston Carpenter Sprenkle ,M.D. | Faculty | Nothing to Disclose | |||
| Samir Taneja, MD | Director | Elsevier Insightec Mdx Health Biobot | Health Publishing Consultant or Advisor Scientific Study or Trial Consultant or Advisor | Yes Yes Yes No | 10/28/2017 01/31/2018 01/31/2018 01/31/2018 |
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this live activity and enduring material for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
Off-label or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.
Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.
Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk
Available Credit
- 5.50 AMA PRA Category 1 Credit™
- 5.50 Non-Physician Participation